Matrix metalloproteinases (MMPs) are a family of endopeptidases that degrade the components of the extracellular matrix (ECM) such as collagen, and thus contribute to the remodelling and the physiological homeostasis of the ECM and its blood supply. The activities of these enzymes are regulated by endogenous tissue inhibitors of metalloproteinases (TIMPs), and it has been suggested that a balance between MMPs and TIMPs plays an important role in vascular remodelling, angiogenesis and vasodilatation in a number of physiological situations. It follows that, regarding a relationship between MMPs and TIMPs, an imbalance between these molecules may lead to pathology in a wide range of conditions, including hypertension, cancer and pulmonary disease, and in the pathophysiology of reproduction. Indeed, regarding the latter, abnormalities in the maternal peripheral vasculature have been proposed as being (partly) responsible for the effects of hypertension on pregnancy and the development of complications including pre-eclampsia and eclampsia. However, the associations between MMPs, TIMPs and disease may be simply of association, not of pathology. This brief review explores current literature on the role of abnormalities of the ECM in general, focusing on the pathogenesis of hypertension and its complications during pregnancy as a model of disordered angiogenesis and remodelling.
INTRODUCTION
Matrix metalloproteinases (MMPs) are a family of endopeptidases that degrade the connective tissue components of the extracellular matrix (ECM), and thus contribute to the physiological homeostasis of the ECM, in vascular remodelling, and in angiogenesis.
1 --4 The activity of these enzymes are regulated by endogenous tissue inhibitors of metalloproteinases (TIMPs), and it has been suggested that a balance between MMPs and TIMPs is also important in the fine tuning of vasomotor control in hypertension and left ventricular hypertrophy, 5 --12 and in the changes in the uterine and systemic vasculature during normal and abnormal pregnancy.
13 --15 To achieve our aim of a brief review on the relevance of MMPs and TIMPs for human pregnancy-related hypertension and its complications, we performed an on-line search of publication databases Cochrane Reviews, PubMed, MEDLINE and EMBASE, using the key words extracellular matrix, matrix metalloproteinases, tissue inhibitors of metalloproteinases, pregnancy, pre-eclampsia and eclampsia.
The elucidation of the cell biology of MMPs followed their original description as macrophage and neutrophil products acting on collagen, but they are now known to be produced by many tissues and cell types, including osteoblasts, human umbilical vein endothelial cells, smooth muscle cells and keratinocytes, and to have wide range of substrates.
16 --19 They may be either secreted from the cell or anchored to the plasma membrane, and often bind with heparin sulphate glycosaminoglycans on the cell surface. Different MMPs have specific and defined characteristics, whereas others are ubiquitous. For example, MMP-12 (metalloelastase) is produced mainly by macrophages and is essential for macrophage migration, whereas MMP-19 (stromelysin-4) was identified by cDNA cloning from the liver and as a T-cell-derived autoantigen from patients with rheumatoid arthritis. 19, 20 MMPs may be divided into six groups, and, to a varying degree, some or all act on aggregan, collagens (types I --XI), decorin, entactin, fibronectin, gelatin, laminin, prelecan, proteoglycan, tenascin and vitronectin, as well as on their own (that is, in auto-activation) or other pro-MMPs (Table 1) .
Several groups hypothesised a physiological function of TIMPs in regulating MMPs, 21 --23 and that their dynamics may be important in diseases such as cancer (and the development of metastases) and liver disease, although TIMPs are not the only MMP regulators. 24 --27 The four best-characterised TIMPs (sublabelled 1, 2, 3 and 4) are coded for on the X chromosome and chromosomes 3, 17 and 22, share 30 --40% amino-acid homology and have a relative molecular mass of around 25 --30 kDa.
7, 28 --30 Although the biology of TIMPs is generally linked to that of MMPs, there are situations where TIMPs offer interesting insights independently of MMPs, notably in cardiovascular disease. 31 --33 A commonly postulated paradigm is that a major physiological role of MMPs is probably to (partially) digest the ECM and thus facilitating remodelling and angiogenesis, and that the TIMPs regulate the activity of the MMPs.
1 --4, 34 It follows that the ratio of MMPs to TIMPs may be crucial, although of course each MMP may be inhibited by one or more TIMP species, and not necessarily of a stoichiometry of one molecule of active enzyme to one molecule of inhibitor. 31,35 --38 However, there is evidence that MMPs/TIMPs also act not only on the inert structural glycoproteins of the ECM, but also on, for example, the endothelial cell. 39, 40 Nevertheless, there is a strong paradigm that the failure of the MMP/TIMP system promotes disease, as has been postulated in cancer. 36, 41, 42 Furthermore, MMPs have recently been implicated in apoptosis. 43 However, MMPs are present in the cytoplasm, and the contribution of these to cell biology and the pathogenesis of hypertension and vascular biology are unknown, as are roles for receptor shedding.
MMPs AND TIMPs IN HYPERTENSION
Originally defined by enzyme assays and zymography, the development of enzyme-linked immunosorbent assays (ELISA) has enabled the rapid measurement of MMPs and TIMPs in the plasma and serum. However, although convenient, ELISA provides only structural activity, and possibly also free enzyme and that which is complexed to an inhibitor, and thus biologically inert. Zymography, on the other hand, evaluates all the MMP degrading potential, as MMPs bound to TIMPS are denatured, made to run into the gel and renatured at a point where TIMPs are not present. In one of the first, Laviades et al., 44 measuring serum MMP-1 and TIMP-1 by ELISA, reported that systemic extracellular degradation of collagen type I is depressed in patients with essential hypertension and can be normalized by treatment with an ACE inhibitor. They suggested that depressed degradation of collagen type I may facilitate organ fibrosis in hypertensive patients, whereas Li-Saw-Hee et al. 45 reported that ELISA-defined MMP-9 and TIMP-l are depressed in hypertensive patients and were not significantly affected by short-term antihypertensive treatment. However, others found raised MMPs and TIMPs. Derosa et al.
5
recruited 44 hypertensive patients and 44 controls, finding increased structural presence and activity of MMP-2, MMP-9 and TIMP-1, and suggested that this reflected abnormal ECM metabolism. Tan et al.
6 confirmed this in a far larger cohort of 202 essential hypertensive patients and 54 control subjects, but also showed that MMP-9 and TIMP-1 were significantly and positively correlated with carotid to femoral pulse wave velocity. Interestingly, a 6-month treatment with a calcium channel blocker normalized plasma active MMP-9 but not MMP-2, 46 raising the interesting possibility that antihypertensive treatment may modulate collagen metabolism.
Pathophysiological roles for MMPs, TIMPs and their ratio are hypothesised in other cardiovascular diseases. 47 --56 Of the different variants, MMP-9 and TIMP-1 seem most useful in a predictive manner, and there are reports of their value as markers of the increased incidence of, and risk of, cardiovascular mortality and morbidity in elderly men. 57, 58 Tayebjee et al. 59 correlated the Framingham CHD risk score and MMP-9 in hypertensive patients, whereas Yasmin et al. 60 correlated ELISA-defined MMP-9 and arterial stiffness in normotension and hypertension, and McNulty et al. 61 found that the ratio of collagen type I synthesis to degradation was negatively correlated with both pulse wave velocity and a vascular augmentation index, whereas plasma ELISA-defined MMP-1 displayed a positive correlation with both indices. However, although workers have provided correlation data, this does not imply causation and the relationship may simply be an association free of pathological significance. A possible role of ELISA-defined MMP in the remodelling of the left ventricle in hypertension has also been described.
7,8,62 --64
MMPs AND TIMPs IN REPRODUCTIVE BIOLOGY Pregnancy is perhaps the most obvious major model of profound physiological tissue remodelling. However, it is also the subject of a unique disease process, with the development of hypertension, that is, systolic and diastolic blood pressures 4140/90 mm Hg. This is the reverse of physiology where blood pressure falls in pregnancy. 15 Hypertension may then involve the kidneys, leading to proteinuria, this stage being defined as pre-eclampsia, and so ultimately to life-threatening eclampsia. 65 --67 The exact aetiology of these complications remain unclear, although Page 68 was one of the first to summarise the pathophysiology of eclampsia, while one of the first hypotheses focused on abnormal vascular function and the over-production of vasoactive substances such as angiotensin II by the foetal/placental system that then influence the maternal circulation, 69 an hypothesis subsequently refined by others. 70 Other hypotheses predicted a role for factors such as endothelial cell activation, misdirected immune activity (possibly related to cytokine activity), nitric oxide, and that cytotrophoblast invasion is shallow, possible because of failure to express adhesion molecules such as integrins and cadherin. 71 --73 However, given their involvement in remodelling (which the uterus clearly undergoes), there is also evidence of a role or roles for abnormalities in the MMP/TIMP system in the pathologies related to pregnancy. 21,74 --76 In addition, placentation is also a strong model of angiogenesis, 77 --79 and the MMP/TIMP system is involved in this process and may also be related to the major complication of pre-eclampsia.
3, 80, 81 MMPs and TIMPS in normal pregnancy MMPs may be involved in placental/uterine interactions at a number of levels throughout pregnancy. Isaka et al. 82 reported immunohistochemical evidence of MMP-2 expression in extravillous trophoblasts and of MMP-9 in villous cytotrophoblasts, with marked zymographic enzyme activity in those extravillous trophoblasts that also expressed MMP-2. However, in term placentas, while there was MMP-2 expression, enzyme activity e Also known as macrophage elastase or metalloelastase. Substrates for all groups generically are collagens I, II, III, IV, V, VII, VIII, X, XI and XIV, aggrecan, gelatin, fibronectin, laminin and proteoglycan, although there is considerable intra-and intergroup specificities, for example, MMPs 1 and 2 have many substrates, MMPs 17 and 24, and act only on fibrin and gelatin, whereas MMP11 does not cleave collagen. Full substrate specificities of some are as yet unknown. Data pooled from references.
13,21,101 --104
was decreased or absent. Enzyme activity was present in purified cytotrophoblast cells early in pregnancy, but in late pregnancy gelatinase activity disappeared. Furthermore, the ability of cytotrophoblasts to invade tissues was inhibited by TIMP-2 and antibodies to MMP-2, suggesting that invasive ability may be regulated by the gelatinase activity of MMP-2.
This hypothesis is supported by reports of polarized release of MMP-2 and MMP-9 (as defined by in situ immunohistochemistry, western blot analysis and zymography of lysates and culture supernatants) from cultured human placental syncytiotrophoblasts, 83 and may explain raised MMP-9 in normal pregnancy.
15
This increase, alongside a lower TIMP-1 level, leads to an increase in MMP/TIMP ratio in normal pregnancy, and the tempting speculation that this reflects healthy remodelling. These studies emphasise the importance of temporal regulation of MMPs in performing specific functions during the gestation, and increases in the plasma levels of MMPs have also been detected during normal pregnancy, suggesting their role in the pregnancy-associated changes in vascular function. 15, 84 In addition, MMPs probably play a role in the uterine artery remodelling during pregnancy and may help maintain uterine blood flow in late pregnancy. In an animal model, continued elevated levels of some MMPs post-partum may contribute to vessel regression and return to a non-pregnant physiological state. 85 MMPs have been suggested to promote decidualisation, an important prerequisite for successful implantation, as studies have shown endometrial production of pro-MMP-2, -3, -7, -9 and active MMP-2. 86 There are few animal data of MMPs and TIMPs in this setting. Although an extreme model, MMP-9 knockout mice (with no MMP ¼ 9 activity in spleen cell lysates) have reduced fertility 87 (http://jaxmice.jax.org/strain/004104.html). However, there are no data with regard to the blood pressure of these animals or the nature of the impairment.
MMPs and TIMPs in the hypertension of pregnancy With a frequency of 2 --3%, hypertension is one of the most common medical problems encountered during pregnancy. 88 Hypertensive disorders are the second leading cause, after venous thrombo-embolism, of maternal mortality in the United States, accounting for almost 15% of such deaths. Hypertensive disorders occur in 6 --8% of pregnancies and contribute significantly to nephropathy, inter-uterine growth retardation, pre-eclampsia, eclampsia, stillbirths and neonatal morbidity and mortality. 65 --67 By excluding women with proteinuria (and thus pre-eclampsia), Tayebjee et al. 15 failed to find the increase in immunologically defined MMP-9, or the increase in MMP/TIMP ratio that is present in normal pregnancy, leading to the speculation of a link with vascular pathology. These findings contrast with those of Palei et al., 89 who found an increase in pro-MMP-9, and the pro-MMP-9/ TIMP-1 ratio in gestational hypertension, possibly as MMP and TIMP concentrations were measured in plasma samples by gelatin zymography and ELISA, respectively. They found measurement of pro-MMP-2 to be unhelpful. Thus, there is little convincing or consistent data in this condition, which bridges a healthy pregnancy and pre-eclampsia.
MMPs and TIMPs in pre-eclampsia As pre-eclampsia is the next step in the pathology of eclampsia, we would expect differences compared with gestational hypertension, as has been demonstrated. 90 --92 Zymographically defined plasma MMP-2 is elevated in the plasma of women with preeclampsia, 91 as well as in those who subsequently develop preeclampsia, suggesting that increased net MMP-2 activity probably contributes to endothelial dysfunction that is central to the pathophysiology of pre-eclampsia. 92 Interestingly, zymographic and immunologically defined MMP-2 is elevated in mid-trimester amniotic fluid before the development of pre-eclampsia. 93 Montagnana et al.
14 found immunologically defined MMP-2 levels to be significantly higher in pre-eclampsia compared with both non-pregnant and normotensive pregnant women, and that MMP-9 was significantly higher in physiological pregnancy compared with non-pregnant women. The serum TIMP-1 was significantly higher in pre-eclampsia compared both nonpregnant and normotensive pregnant women, whereas TIMP-2 values were higher in normotensive pregnant women and preeclamptic women compared with non-pregnant women. They also found a positive correlation between MMP-9 values and gestational age in normal pregnant women that was absent in pre-eclampsia, speculating that the balance between MMPs and their inhibitors plays a greater role in the structural and functional vascular changes of women with complicated pregnancies.
In contrast to serology, direct study on the healthy placenta is understandably very difficult, if not impossible. However, de Jager et al. 94 ingeniously obtained syncytiotrophoblast membrane microvesicular particles from peripheral blood and used them to test the hypothesis that proteases intrinsic to these particles cause endothelial changes in vitro, and thus the presumed hypertension. However, they were unable to demonstrate that the inhibitor effect of these vesicles was due to the presence of the gelatinasae activity of MMP-9. Gallery et al. 95 obtained decidual endothelial cells from normal and pre-eclamptic pregnancies, which they stimulated with tumour necrosis factor-a and transforming growth factor-b, both thought to have significant roles in the control of placentation. 96 Using zymography, western blotting, ELISA and Northern analysis, they concluded that lower MMP-1 expression of decidual endothelial cells from pre-eclamptic women may inhibit endovascular invasion by cytotrophoblasts, which may, at least partly, explain the relative failure of trophoblasts to invade maternal decidua.
Blood from the post-partum umbilical circulation provides the opportunity to test the hypothesis that the placenta is a source of the increased plasma MMPs and TIMPs. Using western immunoblots, immunoenzymatic assay (ELISA) and zymography techniques for the detection of gelatinases and their inhibitors, Galewska et al. 97, 98 showed that the umbilical cord plasma of pre-eclamptic subjects contained large amounts of MMP-9 in the form of complexes with other plasma components, and that zymographic analysis demonstrated increased gelatinolytic activity corresponding to MMP-9, compared with control samples. By contrast, MMP-2, MMP-7, MMP-26, TIMP-1 and TIMP-2 data showed no significant differences between pre-eclamptic and control samples. Table 2 summarises selected data on serum and amniotic MMPs and TIMPs in reproductive biology.
LIMITATIONS
The first problem with MMP and TIMP work is of the definition of the molecule. Immunoassay certainly lends itself to rapid and bulk estimations, but may also measure free molecule and/or that proportion that binds to an inhibitor, substrate or other molecule. In this respect, direct enzyme activity (zymography) may be better as a more direct bio-marker and proof of activity, and some workers have been aciduous in providing structural and bioactive data. Lack of consensus may be a direct consequence of the variability of methods. An additional problem is that some circulating leukocytes are containers of MMPs, so that plasma levels may reflect an underlying immunological or inflammatory process. Furthermore, as clotting activates neutrophils, then there may be artefactually higher levels in the serum compared with the plasma. It is likely that some MMPs may remain active while bound to a cell or tissue, and this would not be measured in a sample of peripheral blood. Indeed, Fridman et al. 99 suggest that the association of MMP-9 with the cell surface is mediated by a distinct collection of surface proteins that serve to regulate several aspects of enzyme function, such as internalisation, inhibition and localisation. However, the greatest problem is the lack of data showing a relationship between plasma or serum levels of MMPs and TIMPs and the activity of these molecules in the relevant tissues, that is, the arteries, the left ventricle, the uterus and elsewhere. The overwhelming assumption is that this is the case, but data are scarce. Significantly higher MMP-9 and lower TIMP-1, as well as MMP-9/TIMP-1 ratios in normotensive pregnant women compared with non-pregnant controls. Higher TIMP-2 levels in the GH group. Negative correlation between MMP-9 and MMP-9/TIMP-1 with age and diastolic blood pressure. Palei et al.
89
GH (26), pre-eclampsia (27) , normotensive pregnant women (30) , non-pregnant healthy women (30) MMP-2 MMP-9 TIMP-1 TIMP-2
Higher pro-MMP-9 levels and higher pro-MMP-9/TIMP-1 ratios in women with GH. No significant differences in pr-MMP-2 levels.
Montagnana et al.
14 Pre-eclampsia (14), normotensive pregnant women (37), non-pregnant healthy women (21) MMP-2 MMP-9 TIMP-1 TIMP-2
Significantly raised MMP-2 and TIMP-1 levels in pre-eclampsia compared with other two groups. MMP-9 and TIMP-2 levels higher in the normotensive pregnant group compared with non-pregnant controls.
Positive correlation between MMP-9 levels and gestational age in normotensive pregnant women. Lavee et al.
93
GH (26), normotensive pregnant women (30) MMP-2 TIMP-2
Mean amniotic MMP-2 and TIMP-2 higher in women with GH; significantly higher MMP-2 levels in those who eventually developed pre-eclampsia.
Abbreviations: GH, gestational hypertension; MMP, matrix metalloproteinase; TIMP, tissue inhibitors of metalloproteinase.
CONCLUSIONS
The ECM is an important component of vascular biology, and is remodelled by MMPs and their regulators, TIMPs, potentially leading to roles for the latter in angiogenesis. 1 --4 Failure of the MMP/TIMP system to control the ECM may lead to diverse pathology. The complex inter-relationships of MMPs and TIMPs may be important in the most severe disease of pregnancy, preeclampsia, as alterations in the relative concentrations of the molecules may have profound effects on the homeostatic mechanisms that control blood pressures in the mother 13 --15,100 ( Figure 1 ). This in turn results in the development of complications of hypertension in pregnancy including pre-eclampsia --eclampsia and poor maternal and possibly foetal outcomes. However, given the current knowledge, attempts to therapeutically manipulate levels of MMPs and/or TIMPs with the objective of reducing the risk of pre-eclampsia seem remote, if impossible. Nevertheless, more precise measurement of these molecules may help identify those women at greatest risk of this most severe obstetric problem.
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